This trial is for children under 18 who have chronic myeloid leukemia (CML) with specific lab findings (Philadelphia-positive and/or BCR-ABL positive). It aims to test a treatment approach in pediatric patients with this form of CML.

This study looks at how a type of white blood cell (monocyte) affects myeloproliferative neoplasms, a group of blood cancers. It aims to help doctors better understand these diseases and improve treatment.

This Phase 2 trial tests a combination of medicines to treat Philadelphia chromosome–positive (Ph-positive) or BCR-ABL–positive acute lymphoblastic leukemia (ALL), including cases that have come back or did not respond. It may help by targeting specific leukemia signals while also aiming to improve disease control.

This study looks at heart and blood vessel problems in people with certain blood cancers called myeloproliferative neoplasms (MPNs), including essential thrombocythemia, polycythemia vera, and primary myelofibrosis. It aims to understand how these conditions affect the heart and blood vessels, which may lead to better care.

This is a research registry for people who have certain blood cancers called myeloproliferative neoplasms (MPNs). It helps researchers learn about the disease over time and may help future studies find and compare patients.

This study collects health information and blood samples from people with myelodysplastic syndrome (MDS) or related conditions over time. It aims to better understand these diseases and improve future care.